How We Mark Time and How Time Marks Us
Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.
A Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends
Dr. Roberts discusses a trial that looks at new therapies to be tested for the treatment of a rare cancer, cutaneous T cell lymphoma.
The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights from published articles in a convenient audio format. All of the podcasts are available for FREE! Learn more
Where to Listen
Listen to the podcasts below (Internet connection required) or download and listen to them later via SoundCloud or iTunes.
In this podcast, Outgoing Editor-in-Chief of The Hematologist Dr. Jason Gotlib gives a warm welcome to Editor-in-Chief Designee Dr. Laura Michaelis. Dr. Michaelis' term begins in 2018. They discuss her vision for the publication including The Hematologist's digital presence, multimedia efforts, new columns, and untapped topics that require attention. Learn more
In his Diffusion article from the September/October 2017 issue of The Hematologist, Dr. Jonathan Hoggatt discusses efforts to grow hematopoietic stem cells to care for patients with diseases that can be treated with bone marrow transplantation. He covers a Nature article co-authored by Dr. George Daley, Dean of Harvard Medical School. In this podcast, Dean Daley joins Dr. Hoggatt for a thought provoking conversation about these efforts. Read more
In this podcast, Drs. Adam Cuker, Holger Schünemann, Mary Cushman and Paul Monagle talk about new ASH Guidelines on VTE, an ASH project started in 2015 to develop 10 evidence-based clinical practice guidelines on the diagnosis and treatment of venous thromboembolism (VTE), in collaboration with the McMaster University GRADE center. Two of these 10 guidelines are now available for public comment, and these members of the panels urge you to provide your input by the deadline of August 25, 2017. Part 1 of the podcast features a conversation between Dr. Cuker and Dr. Schünemann (starting at 2:50 min), and Part 2 features Dr. Cushman conversing with Dr. Monagle (starting at 26:00 min). Comment here
In her Diffusion article from the July/August 2017 issue of The Hematologist, Dr. Lori-Ann Linkins takes a look at the EINSTEIN CHOICE Study and compares reducing the intensity of anticoagulant therapy or switching to aspirin as options for patients who wish to continue being protected from the risk of VTE. She covers a New England Journal of Medicine article co-authored by Dr. Jeffrey Weitz. In this podcast, Dr. Weitz joins Dr. Linkins for a discussion of the study's design, rationale and important findings. Read more
In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin, update ASH members on key policy topics affecting hematologists. They discuss the current political climate and its effects on issues impacting the field of hematology, including research funding, drug access and pricing issues, and efforts to repeal the Affordable Care Act. Drs. Rosmarin and Alvarnas provide information about ASH programs and resources hematologists, whether clinicians or researchers, can use to advocate for issues of importance to them and their patients. Learn more
September-October 2017Volume 14, Issue 5
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology